Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,403,627,461
+$35,389,461 QoQ
Shares Held
13,401,691
-2.7% QoQ
Ownership
0.556%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#26
of 4,647 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 77%
None 23%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$17,985,740
PutShares
97,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. JNJ ranks #2 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,403,627,461 | 13,401,691 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,368,238,000 | 13,779,406 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,782,740,756 | 13,446,440 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,985,740 | 97,000 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $2,442,780,743 | 13,174,311 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,016,318,024 | 13,200,118 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,202,784,721 | 13,282,590 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,943,381,140 | 13,437,845 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,313,244,113 | 14,273,998 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,100,961,863 | 14,374,397 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,154,578,959 | 13,620,197 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,963,143,889 | 12,524,843 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,802,710,462 | 11,574,385 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,349,896,375 | 14,197,054 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,313,405,070 | 14,925,194 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $3,086,027,448 | 17,469,728 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,133,890,231 | 19,183,951 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,469,909,915 | 19,547,687 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,722,090,346 | 21,001,469 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,614,440,345 | 21,128,429 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,214,908,147 | 19,906,552 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,185,355,307 | 19,335,652 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,006,833,210 | 18,295,304 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,142,720,901 | 19,968,998 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,880,508,054 | 19,347,851 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,688,575,307 | 19,118,078 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,282,441,040 | 17,405,941 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||